ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 429 out of 2094

$455K Total Retail Price of All Prescriptions

Rank: 568 out of 2094

300 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 300 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 300 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 5,093 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 335 237 1 1
LISINOPRIL 283 203 2 7
METOPROLOL TARTRATE 229 196 3 10
AMLODIPINE BESYLATE 228 176 4 2
OMEPRAZOLE 208 167 5 4
ZOLPIDEM TARTRATE 167 115 6 14
FAMOTIDINE 162 138 7 34
ATORVASTATIN CALCIUM 157 110 8 5
FUROSEMIDE 149 130 9 6
LEVOTHYROXINE SODIUM 136 106 10 3
GLIPIZIDE ER 114 88 11 126
METFORMIN HCL 101 76 12 8
ENALAPRIL MALEATE 91 73 13 25
GLIPIZIDE XL 91 72 13 122
PROAIR HFA 86 37 15 45
WARFARIN SODIUM 81 81 16 11
CLOTRIMAZOLE-BETAMETHASONE 77 59 17 91
METOPROLOL SUCCINATE 77 55 17 9
ADVAIR DISKUS 76 38 19 36
MELOXICAM 75 65 20 49
DONEPEZIL HCL 70 68 21 20
CLOPIDOGREL 66 51 22 22
CIPROFLOXACIN HCL 65 53 23 81
CLOBETASOL PROPIONATE 65 39 23 160
AZITHROMYCIN 64 46 25 27
TAMSULOSIN HCL 61 39 26 29
OXYCODONE-ACETAMINOPHEN 58 20 S2 27 40
IBUPROFEN 58 39 27 73
TRAMADOL HCL 57 37 29 33
CARVEDILOL 57 49 29 19
POTASSIUM CHLORIDE 57 46 29 24
CLONIDINE HCL 57 36 29 62
LACTULOSE 56 30 33 65
CRESTOR 54 47 34 15
HYDROCODONE BIT-IBUPROFEN 53 30 S3 35 279
NIFEDIPINE ER 52 47 36 96
ESCITALOPRAM OXALATE 50 41 37 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.